Brian C. Stephenson - Dec 10, 2024 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Secretary, Treasurer & CFO
Signature
/s/ Brian C. Stephenson
Stock symbol
BBIO
Transactions as of
Dec 10, 2024
Transactions value $
$0
Form type
4
Date filed
12/12/2024, 07:00 PM
Previous filing
Nov 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBIO Restricted Stock Units Award $0 +42.7K $0.00 42.7K Dec 10, 2024 Common Stock 42.7K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 The RSUs vest with respect to 1/2 of the underlying shares on December 12, 2025. Thereafter, the remaining underlying shares shall vest on December 12, 2026, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.